CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice.
María Latorre-LealPatricia Rodriguez-RodriguezLuca FranchiniOrestis NikolidakisMakrina DaniilidouLjerka DelacMukesh K VarshneyLuis Enrique Arroyo-GarcíaFrancesca EroliBengt WinbladKaj BlennowHenrik ZetterbergMiia KivipeltoManuela PacciariniYuqin WangWilliam J GriffithsIngemar BjörkhemAnna Sandebring-MattonIvan NalvartePaula Merino-SerraisAngel Cedazo-MínguezSilvia MaioliPublished in: Science advances (2024)
The brain-specific enzyme CYP46A1 controls cholesterol turnover by converting cholesterol into 24 S -hydroxycholesterol (24OH). Dysregulation of brain cholesterol turnover and reduced CYP46A1 levels are observed in Alzheimer's disease (AD). In this study, we report that CYP46A1 overexpression in aged female mice leads to enhanced estrogen signaling in the hippocampus and improved cognitive functions. In contrast, age-matched CYP46A1 overexpressing males show anxiety-like behavior, worsened memory, and elevated levels of 5α-dihydrotestosterone in the hippocampus. We report that, in neurons, 24OH contributes to these divergent effects by activating sex hormone signaling, including estrogen receptors. CYP46A1 overexpression in female mice protects from memory impairments induced by ovariectomy while having no effects in gonadectomized males. Last, we measured cerebrospinal fluid levels of 24OH in a clinical cohort of patients with AD and found that 24OH negatively correlates with neurodegeneration markers only in women. We suggest that CYP46A1 activation is a valuable pharmacological target for enhancing estrogen signaling in women at risk of developing neurodegenerative diseases.
Keyphrases
- low density lipoprotein
- high fat diet induced
- working memory
- bone mineral density
- polycystic ovary syndrome
- white matter
- estrogen receptor
- cerebral ischemia
- cerebrospinal fluid
- cell proliferation
- resting state
- spinal cord
- type diabetes
- insulin resistance
- cognitive impairment
- signaling pathway
- magnetic resonance
- multiple sclerosis
- magnetic resonance imaging
- metabolic syndrome
- spinal cord injury
- adipose tissue
- functional connectivity
- computed tomography
- mild cognitive impairment
- physical activity
- depressive symptoms
- breast cancer risk
- contrast enhanced